Abstract
PO-350 Autophagy and mTOR inhibition as mechanisms for combatting chemoresistance to standard chemotherapy: Final results of a phase I study of infusional cyclophosphamide (cy), pulse dexamethasone (dex), rapamycin (rapa) and hydroxychloroquine (HCQ) E.C. Scott, S. Reasor-Heard, K. Floyd, B. Park, P. Trubowitz, E. Medvedova, S.E. Spurgeon, S.D. Smith, A. Kratz, M. Gordon, M. Siegel, S.Q. Liu, R. Arora, M. Loriaux, E. Stadtmauer, R. Amaravadi, D.T. Vogl, R.T. Maziarz The Knight Cancer Institute, Oregon Health and Science University; The Abramson Cancer Center, the University of Pennsylvania
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
